Latest News and Press Releases

- Industry veteran brings over 25 years of financial and operational management experience with a proven track record of developing and implementing successful strategies to drive growth and build...

NEW HOPE, Pa., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address...

Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and hypertension        Financing structure provides for up to an additional...

- Novel Treatment Delivers Immediate, Substantial, and Sustained Reduction in Blood Pressure -   - Potential to Become a Broadly Applicable Therapy for Device-Based Hypertension Management - NEW...

– Ron Dadino appointed Vice President, Pharmaceutical Development & Operations, Cardiovascular Interventions – – Greg Kopia, Ph.D., CMPP appointed Director, Pre-Clinical Development,...

Eric A. Rose, M.D., biotech and medical device business leader as well as world-renowned cardiac surgeon and scientist who performed the landmark achievement of the first successful pediatric heart...

- Ms. Wheeler brings extensive track record in marketing, strategy and commercial program development - NEW HOPE, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed”...

Immediate, Substantial, and Sustained Reduction in Blood Pressure Demonstrates Potential to Offer Highly Differentiated, Breakthrough Treatment for Hypertension SAN DIEGO, Sept. 25, 2018 (GLOBE...

Excellent Long-Term Safety and Efficacy Profile Demonstrate Potential to Offer Valuable New Treatment for Coronary In-Stent Restenosis SAN DIEGO, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) --...